Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
Crossref DOI link: https://doi.org/10.1186/s13048-016-0270-7
Published Online: 2016-09-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pelissier, Aurélie
Roulot, Aurélie
Guéry, Béatrice
Bonneau, Claire
Bellet, Dominique
Rouzier, Roman